Center for Molecular and Translational Human Infectious Diseases Research, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, Texas, USA.
Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA.
mBio. 2020 Oct 30;11(6):e02707-20. doi: 10.1128/mBio.02707-20.
We sequenced the genomes of 5,085 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains causing two coronavirus disease 2019 (COVID-19) disease waves in metropolitan Houston, TX, an ethnically diverse region with 7 million residents. The genomes were from viruses recovered in the earliest recognized phase of the pandemic in Houston and from viruses recovered in an ongoing massive second wave of infections. The virus was originally introduced into Houston many times independently. Virtually all strains in the second wave have a Gly614 amino acid replacement in the spike protein, a polymorphism that has been linked to increased transmission and infectivity. Patients infected with the Gly614 variant strains had significantly higher virus loads in the nasopharynx on initial diagnosis. We found little evidence of a significant relationship between virus genotype and altered virulence, stressing the linkage between disease severity, underlying medical conditions, and host genetics. Some regions of the spike protein-the primary target of global vaccine efforts-are replete with amino acid replacements, perhaps indicating the action of selection. We exploited the genomic data to generate defined single amino acid replacements in the receptor binding domain of spike protein that, importantly, produced decreased recognition by the neutralizing monoclonal antibody CR3022. Our report represents the first analysis of the molecular architecture of SARS-CoV-2 in two infection waves in a major metropolitan region. The findings will help us to understand the origin, composition, and trajectory of future infection waves and the potential effect of the host immune response and therapeutic maneuvers on SARS-CoV-2 evolution. There is concern about second and subsequent waves of COVID-19 caused by the SARS-CoV-2 coronavirus occurring in communities globally that had an initial disease wave. Metropolitan Houston, TX, with a population of 7 million, is experiencing a massive second disease wave that began in late May 2020. To understand SARS-CoV-2 molecular population genomic architecture and evolution and the relationship between virus genotypes and patient features, we sequenced the genomes of 5,085 SARS-CoV-2 strains from these two waves. Our report provides the first molecular characterization of SARS-CoV-2 strains causing two distinct COVID-19 disease waves.
我们对 5085 株导致德克萨斯州休斯顿市两次冠状病毒病 2019(COVID-19)疫情的严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)进行了基因组测序,休斯顿市是一个拥有 700 万居民的种族多样化地区。这些基因组来自在休斯顿大流行最早阶段恢复的病毒,以及正在进行的大规模第二波感染中恢复的病毒。病毒最初是多次独立传入休斯顿的。第二波中的几乎所有菌株的刺突蛋白中都有甘氨酸 614 氨基酸取代,这种多态性与传播和感染性增加有关。最初诊断时,感染甘氨酸 614 变异株的患者鼻咽部病毒载量明显更高。我们发现病毒基因型与毒力改变之间没有明显的关系,这强调了疾病严重程度、潜在的医疗条件和宿主遗传之间的联系。刺突蛋白的一些区域——全球疫苗努力的主要目标——充满了氨基酸取代,这也许表明选择的作用。我们利用基因组数据在刺突蛋白的受体结合域中产生了明确的单一氨基酸取代,重要的是,这会降低中和单克隆抗体 CR3022 的识别。我们的报告代表了对主要大都市地区两次感染浪潮中 SARS-CoV-2 分子结构的首次分析。这些发现将帮助我们了解未来感染浪潮的起源、组成和轨迹,以及宿主免疫反应和治疗措施对 SARS-CoV-2 进化的潜在影响。人们担心在全球最初发生疾病浪潮的社区中,由 SARS-CoV-2 冠状病毒引起的 COVID-19 会出现第二波和随后的波次。德克萨斯州休斯顿市拥有 700 万人口,正在经历一场始于 2020 年 5 月下旬的大规模第二波疫情。为了了解 SARS-CoV-2 分子群体基因组结构和进化以及病毒基因型与患者特征之间的关系,我们对来自这两波的 5085 株 SARS-CoV-2 进行了基因组测序。我们的报告提供了首次对导致两次不同 COVID-19 疫情的 SARS-CoV-2 株的分子特征描述。